FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical is committed to restoring domestic cataract product sales in 2006 after putting its regulatory woes to rest during the fourth quarter